Researchers have shown that adding the RPL6 protein to malaria vaccines was successful at protecting mice against the condition.
List view / Grid view
Filter the results
Using an antibody to a particular malaria protein called PfGARP, researchers have developed a new strategy for designing a malaria vaccine.
A group of researchers has created a free library of 14,000 known macrolactones for other scientists to use in drug development.
A study has shown that the COVID-19 pandemic has resulted in a high level of research donations, making the condition the third most funded disease on average by year.
A study has revealed that a sponge endemic to an Indonesian bay produces manzamine A, a compound which inhibits proteins in cervical cancers.
Researchers have developed a novel affordable and reproducible assay to study the malaria parasite, using a new cytoplasmic dye, Cell Trace Far-Red (CTFR).
A collaborative team has developed a compound called WM382, which targets two crucial enzymes in the malaria parasite, effectively killing it.
Researchers in the United States have used particles from the tobacco mosaic virus (TMV) to produce a new much-needed malaria vaccine.
Researchers have produced a capillary model which allows investigation of the dynamics of blood flow obstruction in real scale and could be used to test new therapies for P. falciparum malaria.
Researchers have been able to watch rhomboid proteases in a native lipid environment which may be useful for the development of Parkinson's and malaria medication.
A new study has identified antibodies that may hold the key to creating the first effective vaccine against malaria infection in the blood.
Researchers have identified a novel drug target for the prevention of malaria.
Cryo-EM was used to image the antibodies attaching to the circumsporozoite protein, which is the most abundant protein on the surface of malaria...
The failure of natural killer cells (NK cells) to respond to infection explains why malaria causes a worse reaction in some patients than others.